"MAP Kinase Kinase 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitogen-activated protein kinase kinase with specificity for a subset of P38 MITOGEN-ACTIVATED PROTEIN KINASES that includes MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 13; and MITOGEN-ACTIVATED PROTEIN KINASE 14.
| Descriptor ID |
D048371
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.565.300 D08.811.913.696.620.682.725.200.300 D12.644.360.440.300 D12.776.476.440.300
|
| Concept/Terms |
MAP Kinase Kinase 3- MAP Kinase Kinase 3
- MEK3 Protein Kinase
- Protein Kinase, MEK3
- MEK-3 Protein Kinase
- MEK 3 Protein Kinase
- MKK3 Protein Kinase
- Protein Kinase, MKK3
- MKK-3 Protein Kinase
- MKK 3 Protein Kinase
- Protein Kinase, MKK-3
- Dual Specificity Mitogen-Activated Protein Kinase Kinase 3
- Dual Specificity Mitogen Activated Protein Kinase Kinase 3
- Mitogen-Activated Protein Kinase Kinase 3
- Mitogen Activated Protein Kinase Kinase 3
|
Below are MeSH descriptors whose meaning is more general than "MAP Kinase Kinase 3".
Below are MeSH descriptors whose meaning is more specific than "MAP Kinase Kinase 3".
This graph shows the total number of publications written about "MAP Kinase Kinase 3" by people in this website by year, and whether "MAP Kinase Kinase 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MAP Kinase Kinase 3" by people in Profiles.
-
Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol. 2011 Feb; 50(2):367-76.
-
TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ. 2010 Aug; 17(8):1288-301.
-
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma. 2009 Dec; 50(12):2017-29.
-
Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. Oncogene. 2003 Sep 18; 22(40):6129-41.
-
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem. 2003 May 23; 278(21):19245-56.